Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
Patients with inactive or occult hepatitis B virus infection and onco-hematological malignancies are at risk for hepatitis flare, hepatic failure and death due to chemotherapy-mediated reactivation. Nucleot(s)ide analogues can reduce reactivation risks and/or hepatitis. However, immuno-mediated phen...
Saved in:
Main Authors: | Alfredo Marzano, Andrea Marengo, Michela di Fonzo, Antonella Ferrari, Bruno Monarca, Gianfranco delle Fave, Massimo Marignani |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2010-12-01
|
Series: | Mediterranean Journal of Hematology and Infectious Diseases |
Subjects: | |
Online Access: | http://www.mjhid.org/index.php/mjhid/article/view/167 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Coexisting patterns and significance of serum HBV RNA and HBV DNA in patients with treatment-naïve chronic hepatitis B virus infection
by: Kun-yan Hao, et al.
Published: (2025-01-01) -
Hepatitis B virus infections in pregnant women and children in the era of HBV elimination
by: Malgorzata Pawlowska
Published: (2024-12-01) -
Modelling and Simulation of The Spread of HBV Disease.
by: Niyirora, Ignatius
Published: (2023) -
Sarcoidosis during HCV antiviral therapy
by: Emanuela De Santis, et al.
Published: (2014-08-01) -
A Sleeping Giant: Late HBV Reactivation After Rituximab-Based Chemotherapy Despite Correct Prophylaxis
by: Nowicka AA, et al.
Published: (2024-12-01)